73.58
Overview
News
Price History
Option Chain
Financials
Why ALC Down?
Discussions
Forecast
Dividend History
Alcon Inc stock is traded at $73.58, with a volume of 2.94M.
It is down -2.35% in the last 24 hours and up +8.51% over the past month.
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.
See More
Previous Close:
$75.35
Open:
$72.34
24h Volume:
2.94M
Relative Volume:
1.31
Market Cap:
$35.57B
Revenue:
$10.63B
Net Income/Loss:
$819.00M
P/E Ratio:
44.39
EPS:
1.6577
Net Cash Flow:
$1.59B
1W Performance:
+4.27%
1M Performance:
+8.51%
6M Performance:
-6.33%
1Y Performance:
-14.47%
Alcon Inc Stock (ALC) Company Profile
Name
Alcon Inc
Sector
Industry
Phone
-
Address
-
Compare ALC vs ISRG, BDX, RMD, MDLN
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
ALC
Alcon Inc
|
73.58 | 36.42B | 10.63B | 819.00M | 1.59B | 1.6577 |
|
ISRG
Intuitive Surgical Inc
|
401.27 | 141.75B | 11.03B | 3.16B | 3.22B | 8.7251 |
|
BDX
Becton Dickinson Co
|
183.58 | 49.41B | 21.37B | 1.41B | 3.07B | 3.9437 |
|
RMD
Resmed Inc
|
226.00 | 32.61B | 5.54B | 1.52B | 1.74B | 10.37 |
|
MDLN
Medline Inc
|
35.50 | 30.74B | 29.14B | 1.07B | 1.05B | 1.1956 |
Alcon Inc Stock (ALC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-26-26 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-30-26 | Initiated | William Blair | Mkt Perform |
| Jan-20-26 | Upgrade | Deutsche Bank | Hold → Buy |
| Jan-09-26 | Downgrade | Stifel | Buy → Hold |
| Dec-11-25 | Downgrade | BofA Securities | Buy → Underperform |
| Aug-21-25 | Downgrade | JP Morgan | Overweight → Neutral |
| May-20-25 | Downgrade | Deutsche Bank | Buy → Hold |
| May-14-25 | Reiterated | BTIG Research | Buy |
| Mar-28-25 | Reiterated | Needham | Buy |
| Mar-25-25 | Upgrade | BofA Securities | Neutral → Buy |
| Jan-24-25 | Reiterated | Needham | Buy |
| Jan-10-25 | Upgrade | Redburn Atlantic | Neutral → Buy |
| Dec-17-24 | Reiterated | Needham | Buy |
| Nov-12-24 | Reiterated | Needham | Buy |
| Oct-10-24 | Upgrade | Redburn Atlantic | Sell → Neutral |
| Sep-10-24 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Jul-15-24 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| May-15-24 | Upgrade | Oppenheimer | Perform → Outperform |
| Apr-10-24 | Initiated | Goldman | Buy |
| Mar-14-24 | Initiated | RBC Capital Mkts | Sector Perform |
| Feb-06-24 | Resumed | KeyBanc Capital Markets | Overweight |
| Jan-23-24 | Initiated | Bernstein | Outperform |
| Dec-18-23 | Downgrade | Redburn Atlantic | Neutral → Sell |
| Dec-12-23 | Initiated | Stifel | Buy |
| Dec-04-23 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Aug-17-23 | Upgrade | JP Morgan | Neutral → Overweight |
| May-30-23 | Resumed | Morgan Stanley | Equal-Weight |
| May-10-23 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Mar-01-23 | Upgrade | Societe Generale | Sell → Hold |
| Dec-22-22 | Initiated | Mizuho | Buy |
| Nov-17-22 | Downgrade | Societe Generale | Hold → Sell |
| Aug-11-22 | Downgrade | Societe Generale | Buy → Hold |
| May-13-22 | Resumed | Credit Suisse | Outperform |
| May-12-22 | Upgrade | Stephens | Equal-Weight → Overweight |
| Apr-08-22 | Initiated | Needham | Buy |
| Mar-11-22 | Initiated | BofA Securities | Buy |
| Jan-18-22 | Downgrade | Stephens | Overweight → Equal-Weight |
| Jan-07-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Oct-01-21 | Initiated | Oppenheimer | Perform |
| Jul-14-21 | Initiated | Deutsche Bank | Buy |
| May-06-21 | Upgrade | Citigroup | Sell → Neutral |
| Mar-22-21 | Upgrade | BTIG Research | Neutral → Buy |
| Nov-12-20 | Downgrade | Guggenheim | Buy → Neutral |
| Jul-06-20 | Downgrade | Citigroup | Neutral → Sell |
| Jul-06-20 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Jun-16-20 | Upgrade | Guggenheim | Neutral → Buy |
| Apr-08-20 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Mar-26-20 | Upgrade | Argus | Hold → Buy |
| Mar-24-20 | Upgrade | Societe Generale | Sell → Hold |
| Mar-13-20 | Upgrade | UBS | Neutral → Buy |
| Mar-05-20 | Initiated | Citigroup | Neutral |
| Feb-26-20 | Upgrade | Berenberg | Hold → Buy |
| Jan-08-20 | Initiated | Argus | Hold |
| Oct-29-19 | Initiated | Stephens | Equal-Weight |
| Aug-21-19 | Reiterated | BofA/Merrill | Neutral |
| Jun-24-19 | Initiated | SVB Leerink | Mkt Perform |
| Jun-14-19 | Initiated | BTIG Research | Neutral |
| May-10-19 | Initiated | Robert W. Baird | Outperform |
| May-02-19 | Initiated | Credit Suisse | Outperform |
View All
Alcon Inc Stock (ALC) Latest News
Tariff refund boosts Alcon’s second quarter results - WFMZ.com
Bernstein raises Alcon stock price target on product launches - Investing.com
Bernstein raises Alcon stock price target on product launches By Investing.com - Investing.com Canada
ALC Maintained by Mizuho -- Price Target Raised to $85.00 - GuruFocus
Alcon’s New-Product Wave Carries Q2 As It Walks Away From Accommodating IOL Bet - insights.citeline.com
Alcon stock slips as profit reset follows stronger Q2 growth - AD HOC NEWS
Mizuho raises Alcon stock price target to $85 on new products - Investing.com Canada
Key facts: Alcon AG (ALC) Q2 sales +7%; Q3 gross margin to rise - TradingView
Alcon Q2 Sales Rise on Strength in Vision Care, Surgical Segments - visionmonday.com
Alcon Inc (ALC) (Q2 2026) Earnings Call Highlights: Strong Sales Growth and Strategic Pivots ... - Yahoo Finance Singapore
ALC Maintains Buy Rating by Needham -- Price Target Raises to $9 - GuruFocus
New Launches and Pipeline Investments Support Alcon's Market Leadership and Strong Fundamentals - Morningstar
How Is Alcon (NYSE:ALC) Tracking on the NYSE Composite Today? - Kalkine Media
BTIG reiterates Buy on Alcon stock after Q2 results beat margins - Investing.com Australia
Swiss Market Index Blinks Red; Alcon Shares Rise - marketscreener.com
AlphaValue sees clear skies ahead for Alcon - marketscreener.com
Alcon Stock Jumps 4% as Tariff Relief Lifts Profit Target - GuruFocus
AlphaValue says the outlook is clear for Alcon - marketscreener.com
Alcon Q2 2026 slides: 7% growth, margin gains despite PowerVision hit - Investing.com
Alcon's Q2 Earnings and Revenues Surpass Estimates, Stock Climbs - TradingView
Alcon : Second-Quarter 2026 Earnings Call Regulatory Filing - marketscreener.com
Alcon CFO On CallHigher Gross Margin In Q3 Due To Tariff Refunds - TradingView
Alcon Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Alcon Inc. (ALC) Q2 FY2026 earnings call transcript - Yahoo Finance
Alcon raises 2026 earnings growth outlook on positive Q2 results - Yahoo Finance
Alcon Lifts 2026 Outlook Amid Higher First-half Sales, Lower Tariff Impact Forecast - marketscreener.com
Alcon Raises 2026 Profit Guidance as Expected U.S. Refund Reduces Tariff Impact - Yahoo Finance
Alcon rises on profit guidance hike, lowered tariff impact estimate By Investing.com - Investing.com Canada
Alcon Jumps 5.7% After Tariff Refund Drives Up 2026 Profit Forecast - TechStock²
Why is Alcon stock surging today? - Investing.com
Eye care company Alcon raises margin outlook, shares jump - TradingView
Alcon Inc. (ALC) Stock Price, News, Quote & History - Yahoo! Finance Canada
Eye care company Alcon raises profitability outlook, cuts tariff hit estimate - 1470 & 100.3 WMBD
Alcon raises its 2026 profit targets - marketscreener.com
Alcon (SWX:ALC), Why Is Its Latest Update Drawing Attention? - Yahoo Finance
Alcon Posts Lower H1 Attributable Net Income; Net Sales Grow - marketscreener.com
Alcon (ALC) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
Why is Alcon stock surging today? By Investing.com - Investing.com Canada
Alcon rises ahead of earnings as investors bet on product momentum - Quiver Quantitative
Alcon Inc. (ALC) Stock Rises on Q2 2026 Earnings - Quiver Quantitative
Alcon shares leap 5% on better-than-expected Q2 results By Investing.com - Investing.com South Africa
Alcon lifts 2026 outlook after Q2 adjusted EPS beat estimates - TradingView
Earnings Flash (ALC) Alcon Inc. Reports Q2 Revenue $2.78B, vs. FactSet Est of $2.76B - marketscreener.com
Press Release: New Product Launches and Strong Commercial Execution Drive Alcon's Second-Quarter 2026 Growth - Moomoo
Alcon earnings up next: Can revenue growth ease margin pressure? - Investing.com
Alcon Inc. (ALC) Stock Analysis: Tapping into a 21.6% Upside Potential in Healthcare Innovation - DirectorsTalk Interviews
Alcon to Use Google(x) Smart Lens Technology | Business | Aug 2014 - Photonics Spectra
Is It Too Late to Buy Alcon Inc (ALC) After 3.3% Rally? GF Value Says Undervalued - GuruFocus
Alcon AG expected to post earnings of 76 cents a shareEarnings Preview - TradingView
Prévisions Alcon: croissance organique légèrement supérieure attendue - TradingView
STAAR Surgical appoints Warren Foust as permanent CEO - MedTech Dive
Alcon Inc Stock (ALC) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):